Annual Operating Profit
-$7.30 M
+$3.30 M+31.14%
December 31, 2023
Summary
- As of February 9, 2025, ABIO annual operating income is -$7.30 million, with the most recent change of +$3.30 million (+31.14%) on December 31, 2023.
- During the last 3 years, ABIO annual operating profit has risen by +$2.47 million (+25.29%).
Performance
ABIO Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Operating Profit
-$3.12 M
-$640.00 K-25.79%
June 30, 2024
Summary
- As of February 9, 2025, ABIO quarterly operating income is -$3.12 million, with the most recent change of -$640.00 thousand (-25.79%) on June 30, 2024.
- Over the past year, ABIO quarterly operating profit has dropped by -$1.53 million (-96.35%).
Performance
ABIO Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Operating Profit
-$9.13 M
-$1.15 M-14.39%
June 30, 2024
Summary
- As of February 9, 2025, ABIO TTM operating income is -$9.13 million, with the most recent change of -$1.15 million (-14.39%) on June 30, 2024.
- Over the past year, ABIO TTM operating profit has dropped by -$1.83 million (-25.15%).
Performance
ABIO TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
ABIO Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.1% | -96.3% | -25.1% |
| 3 y3 years | +25.3% | +33.8% | +51.4% |
| 5 y5 years | +10.1% | +33.8% | +51.4% |
ABIO Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +165.0% | +101.7% | +81.9% | +25.9% | +111.8% |
| 5 y | 5-year | +25.5% | +165.0% | +144.3% | +81.9% | +76.4% | +111.8% |
| alltime | all time | +68.9% | +1826.7% | -111.4% | +2129.0% | +380.6% | +1439.5% |
ARCA Biopharma Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | -$3.12 M(+25.8%) | -$9.13 M(+14.4%) |
| Mar 2024 | - | -$2.48 M(+56.1%) | -$7.98 M(+9.4%) |
| Dec 2023 | -$7.30 M(-31.1%) | -$1.59 M(-17.9%) | -$7.30 M(+0.6%) |
| Sep 2023 | - | -$1.94 M(-1.8%) | -$7.25 M(-7.8%) |
| Jun 2023 | - | -$1.97 M(+9.9%) | -$7.87 M(-13.7%) |
| Mar 2023 | - | -$1.80 M(+16.0%) | -$9.12 M(-14.0%) |
| Dec 2022 | -$10.60 M(-45.2%) | -$1.55 M(-39.3%) | -$10.60 M(-28.1%) |
| Sep 2022 | - | -$2.55 M(-20.7%) | -$14.73 M(-12.8%) |
| Jun 2022 | - | -$3.22 M(-1.8%) | -$16.89 M(-8.7%) |
| Mar 2022 | - | -$3.28 M(-42.3%) | -$18.51 M(-4.3%) |
| Dec 2021 | -$19.34 M(+98.0%) | -$5.68 M(+20.4%) | -$19.34 M(+2.9%) |
| Sep 2021 | - | -$4.72 M(-2.5%) | -$18.78 M(+17.0%) |
| Jun 2021 | - | -$4.84 M(+17.9%) | -$16.05 M(+28.2%) |
| Mar 2021 | - | -$4.10 M(-20.0%) | -$12.53 M(+28.3%) |
| Dec 2020 | -$9.77 M(+68.0%) | -$5.13 M(+157.6%) | -$9.77 M(+65.0%) |
| Sep 2020 | - | -$1.99 M(+51.9%) | -$5.92 M(+14.4%) |
| Jun 2020 | - | -$1.31 M(-2.2%) | -$5.17 M(-3.7%) |
| Mar 2020 | - | -$1.34 M(+4.9%) | -$5.37 M(-7.6%) |
| Dec 2019 | -$5.81 M(-28.4%) | -$1.28 M(+2.5%) | -$5.81 M(-4.1%) |
| Sep 2019 | - | -$1.25 M(-17.3%) | -$6.06 M(-6.4%) |
| Jun 2019 | - | -$1.51 M(-15.3%) | -$6.48 M(-9.1%) |
| Mar 2019 | - | -$1.78 M(+16.6%) | -$7.13 M(-12.2%) |
| Dec 2018 | -$8.12 M(-56.6%) | -$1.53 M(-8.1%) | -$8.12 M(-25.4%) |
| Sep 2018 | - | -$1.66 M(-22.9%) | -$10.89 M(-20.5%) |
| Jun 2018 | - | -$2.16 M(-22.3%) | -$13.70 M(-19.9%) |
| Mar 2018 | - | -$2.77 M(-35.5%) | -$17.10 M(-8.6%) |
| Dec 2017 | -$18.71 M(+12.6%) | -$4.30 M(-4.0%) | -$18.71 M(+0.0%) |
| Sep 2017 | - | -$4.47 M(-19.5%) | -$18.71 M(-1.3%) |
| Jun 2017 | - | -$5.56 M(+26.9%) | -$18.94 M(+9.3%) |
| Mar 2017 | - | -$4.38 M(+2.1%) | -$17.33 M(+4.3%) |
| Dec 2016 | -$16.61 M(+45.0%) | -$4.29 M(-8.9%) | -$16.61 M(+7.2%) |
| Sep 2016 | - | -$4.71 M(+19.6%) | -$15.50 M(+13.9%) |
| Jun 2016 | - | -$3.94 M(+7.4%) | -$13.60 M(+9.9%) |
| Mar 2016 | - | -$3.67 M(+15.5%) | -$12.38 M(+8.1%) |
| Dec 2015 | -$11.46 M(+18.2%) | -$3.17 M(+12.7%) | -$11.46 M(+5.2%) |
| Sep 2015 | - | -$2.82 M(+3.6%) | -$10.89 M(+5.1%) |
| Jun 2015 | - | -$2.72 M(-0.9%) | -$10.36 M(+3.1%) |
| Mar 2015 | - | -$2.74 M(+5.1%) | -$10.05 M(+3.7%) |
| Dec 2014 | -$9.69 M(+39.7%) | -$2.61 M(+14.3%) | -$9.69 M(-3.3%) |
| Sep 2014 | - | -$2.29 M(-5.0%) | -$10.03 M(+5.9%) |
| Jun 2014 | - | -$2.41 M(+0.7%) | -$9.47 M(+14.6%) |
| Mar 2014 | - | -$2.39 M(-18.9%) | -$8.26 M(+19.0%) |
| Dec 2013 | -$6.94 M(+60.7%) | -$2.95 M(+70.8%) | -$6.94 M(+43.6%) |
| Sep 2013 | - | -$1.73 M(+44.0%) | -$4.83 M(+19.8%) |
| Jun 2013 | - | -$1.20 M(+12.0%) | -$4.04 M(+1.3%) |
| Mar 2013 | - | -$1.07 M(+27.5%) | -$3.98 M(-7.8%) |
| Dec 2012 | -$4.32 M(-41.3%) | -$839.00 K(-9.6%) | -$4.32 M(-15.5%) |
| Sep 2012 | - | -$928.00 K(-19.0%) | -$5.11 M(-14.9%) |
| Jun 2012 | - | -$1.15 M(-18.6%) | -$6.01 M(-8.5%) |
| Mar 2012 | - | -$1.41 M(-14.0%) | -$6.57 M(-10.8%) |
| Dec 2011 | -$7.36 M(-19.8%) | -$1.63 M(-10.3%) | -$7.36 M(-8.9%) |
| Sep 2011 | - | -$1.82 M(+6.9%) | -$8.08 M(-3.4%) |
| Jun 2011 | - | -$1.70 M(-22.6%) | -$8.36 M(-6.3%) |
| Mar 2011 | - | -$2.20 M(-6.4%) | -$8.93 M(-2.7%) |
| Dec 2010 | -$9.18 M | -$2.35 M(+11.7%) | -$9.18 M(-39.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | -$2.11 M(-7.2%) | -$15.27 M(-6.2%) |
| Jun 2010 | - | -$2.27 M(-7.3%) | -$16.29 M(-23.8%) |
| Mar 2010 | - | -$2.45 M(-71.0%) | -$21.38 M(-25.9%) |
| Dec 2009 | -$28.85 M(+48.0%) | -$8.45 M(+170.9%) | -$28.85 M(+99.0%) |
| Sep 2009 | - | -$3.12 M(-57.7%) | -$14.50 M(-29.0%) |
| Jun 2009 | - | -$7.37 M(-25.7%) | -$20.42 M(+19.9%) |
| Mar 2009 | - | -$9.92 M(-268.0%) | -$17.03 M(-29.2%) |
| Dec 2008 | -$19.49 M(+17.7%) | $5.90 M(-165.3%) | -$24.05 M(-44.1%) |
| Sep 2008 | - | -$9.04 M(+127.2%) | -$43.02 M(-9.6%) |
| Jun 2008 | - | -$3.98 M(-76.5%) | -$47.61 M(+191.9%) |
| Mar 2008 | - | -$16.94 M(+29.7%) | -$16.31 M(-1.5%) |
| Dec 2007 | -$16.55 M(-88.2%) | -$13.06 M(-4.2%) | -$16.55 M(-77.3%) |
| Sep 2007 | - | -$13.63 M(-149.9%) | -$73.09 M(-17.2%) |
| Jun 2007 | - | $27.32 M(-259.0%) | -$88.25 M(-35.4%) |
| Mar 2007 | - | -$17.18 M(-75.3%) | -$136.52 M(-2.9%) |
| Dec 2006 | -$140.57 M(+92.5%) | -$69.59 M(+141.7%) | -$140.57 M(+51.4%) |
| Sep 2006 | - | -$28.79 M(+37.4%) | -$92.88 M(+12.0%) |
| Jun 2006 | - | -$20.95 M(-1.3%) | -$82.94 M(+4.2%) |
| Mar 2006 | - | -$21.23 M(-3.0%) | -$79.62 M(+8.7%) |
| Dec 2005 | -$73.04 M(+50.1%) | -$21.89 M(+16.1%) | -$73.23 M(+17.9%) |
| Sep 2005 | - | -$18.85 M(+6.9%) | -$62.12 M(+16.0%) |
| Jun 2005 | - | -$17.64 M(+18.7%) | -$53.54 M(+15.1%) |
| Mar 2005 | - | -$14.85 M(+37.8%) | -$46.53 M(-4.3%) |
| Dec 2004 | -$48.64 M(+7.4%) | -$10.78 M(+4.9%) | -$48.65 M(+12.9%) |
| Sep 2004 | - | -$10.27 M(-3.3%) | -$43.07 M(-0.7%) |
| Jun 2004 | - | -$10.63 M(-37.3%) | -$43.40 M(-11.1%) |
| Mar 2004 | - | -$16.96 M(+225.8%) | -$48.84 M(+7.8%) |
| Dec 2003 | -$45.28 M(+24.8%) | -$5.21 M(-50.9%) | -$45.28 M(-9.3%) |
| Sep 2003 | - | -$10.60 M(-34.1%) | -$49.91 M(+23.8%) |
| Jun 2003 | - | -$16.07 M(+19.8%) | -$40.30 M(+28.0%) |
| Mar 2003 | - | -$13.41 M(+36.5%) | -$31.47 M(-14.7%) |
| Dec 2002 | -$36.29 M(+2.6%) | -$9.83 M(+894.7%) | -$36.90 M(-6.5%) |
| Sep 2002 | - | -$988.00 K(-86.4%) | -$39.45 M(-15.6%) |
| Jun 2002 | - | -$7.24 M(-61.5%) | -$46.72 M(-2.3%) |
| Mar 2002 | - | -$18.84 M(+52.2%) | -$47.82 M(+35.2%) |
| Dec 2001 | -$35.37 M(+55.6%) | -$12.38 M(+49.9%) | -$35.37 M(+19.4%) |
| Sep 2001 | - | -$8.26 M(-1.1%) | -$29.62 M(+15.9%) |
| Jun 2001 | - | -$8.35 M(+30.7%) | -$25.56 M(+13.4%) |
| Mar 2001 | - | -$6.39 M(-3.6%) | -$22.54 M(-0.8%) |
| Dec 2000 | -$22.73 M(+14.2%) | -$6.63 M(+57.8%) | -$22.73 M(+5.7%) |
| Sep 2000 | - | -$4.20 M(-21.2%) | -$21.50 M(-2.3%) |
| Jun 2000 | - | -$5.33 M(-18.9%) | -$22.00 M(+1.5%) |
| Mar 2000 | - | -$6.57 M(+21.7%) | -$21.67 M(+7.6%) |
| Dec 1999 | -$19.90 M(+4.2%) | -$5.40 M(+14.9%) | -$20.15 M(+3.6%) |
| Sep 1999 | - | -$4.70 M(-6.0%) | -$19.45 M(-7.2%) |
| Jun 1999 | - | -$5.00 M(-1.0%) | -$20.95 M(+1.9%) |
| Mar 1999 | - | -$5.05 M(+7.4%) | -$20.55 M(+8.1%) |
| Dec 1998 | -$19.10 M(+135.8%) | -$4.70 M(-24.2%) | -$19.00 M(+13.1%) |
| Sep 1998 | - | -$6.20 M(+34.8%) | -$16.80 M(+32.3%) |
| Jun 1998 | - | -$4.60 M(+31.4%) | -$12.70 M(+32.3%) |
| Mar 1998 | - | -$3.50 M(+40.0%) | -$9.60 M(+20.0%) |
| Dec 1997 | -$8.10 M(+62.0%) | -$2.50 M(+19.0%) | -$8.00 M(+45.5%) |
| Sep 1997 | - | -$2.10 M(+40.0%) | -$5.50 M(+61.8%) |
| Jun 1997 | - | -$1.50 M(-21.1%) | -$3.40 M(+78.9%) |
| Mar 1997 | - | -$1.90 M | -$1.90 M |
| Dec 1996 | -$5.00 M | - | - |
FAQ
- What is ARCA biopharma annual operating income?
- What is the all time high annual operating profit for ARCA biopharma?
- What is ARCA biopharma annual operating profit year-on-year change?
- What is ARCA biopharma quarterly operating income?
- What is the all time high quarterly operating profit for ARCA biopharma?
- What is ARCA biopharma quarterly operating profit year-on-year change?
- What is ARCA biopharma TTM operating income?
- What is the all time high TTM operating profit for ARCA biopharma?
- What is ARCA biopharma TTM operating profit year-on-year change?
What is ARCA biopharma annual operating income?
The current annual operating profit of ABIO is -$7.30 M
What is the all time high annual operating profit for ARCA biopharma?
ARCA biopharma all-time high annual operating income is -$4.32 M
What is ARCA biopharma annual operating profit year-on-year change?
Over the past year, ABIO annual operating income has changed by +$3.30 M (+31.14%)
What is ARCA biopharma quarterly operating income?
The current quarterly operating profit of ABIO is -$3.12 M
What is the all time high quarterly operating profit for ARCA biopharma?
ARCA biopharma all-time high quarterly operating income is $27.32 M
What is ARCA biopharma quarterly operating profit year-on-year change?
Over the past year, ABIO quarterly operating income has changed by -$1.53 M (-96.35%)
What is ARCA biopharma TTM operating income?
The current TTM operating profit of ABIO is -$9.13 M
What is the all time high TTM operating profit for ARCA biopharma?
ARCA biopharma all-time high TTM operating income is -$1.90 M
What is ARCA biopharma TTM operating profit year-on-year change?
Over the past year, ABIO TTM operating income has changed by -$1.83 M (-25.15%)